yokohama-cu.ac.jp The clinical features of VEXAS syndrome are heterogeneous, including high-grade fever, polychondritis, large vessel vasculitis, skin eruptions, arthritis, thrombosis, scleritis and ...

Calculating the crude or adjusted annualized relapse rate (ARR) and its confidence interval (CI) is often required in clinical studies to evaluate chronic relapsing diseases, such as multiple ...

5 INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France Objectives To assess the efficacy and the safety of biologics in a cohort of patients with relapsing ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

PIPE-307 is under clinical development by Janssen Pharmaceutica and currently in Phase II for Relapsing Remitting Multiple Sclerosis (RRMS). According to GlobalData, Phase II drugs for Relapsing ...

Remibrutinib is under clinical development by Novartis and currently in Phase III for Relapsing Remitting Multiple Sclerosis (RRMS). According to GlobalData, Phase III drugs for Relapsing Remitting ...

Queensland Health staff in Townsville are treating an elderly man with dengue fever and a middle-aged man with Japanese encephalitis (JEV). The dengue case is Townsville's first breakthrough case ...

When seeing a person with relapsing-remitting MS (RRMS) for the first time, the MS neurologist must address a fundamental question: “What is the nature of the disease activity and likely prognosis of ...